Perspective: An overemphasis on vaccines for Mpox skewes important lessons from COVID-19 and the need for public health approaches
Open Access
- 12 March 2025
- journal article
- review article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (6) , 102749
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Suspected and confirmed mpox cases in DR Congo: a retrospective analysis of national epidemiological and laboratory surveillance data, 2010–23The Lancet, 2025
- Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort studyThe Lancet, 2025
- Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018–2024: Predominance of zoonotic transmissionCell, 2024
- MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settingsVaccine, 2024
- Mpox—is there a more dangerous new clade?The Lancet Infectious Diseases, 2024
- COVAX – Time to reconsider the strategy and its targetHealth Policy OPEN, 2023
- Effect of prior immunisation with smallpox vaccine for protection against human Mpox: A systematic reviewReviews in Medical Virology, 2023
- Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory virusesCell Host & Microbe, 2023
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionThe Lancet, 2022
- Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wagerVaccine, 2021